ART MEDICAL Ltd. is pleased to announce its collaboration with Teva Israel. Under the terms of the agreement, Teva Israel will market and distribute ART MEDICAL's ground-breaking smART+ Platform in Israel's intensive care units.

The clinical nutrition market for the neurological diseases segment is poised to expand at more than 7.9% CAGR through 2027, impelled by the advantages of enteral and parenteral nutrition in patients with neurological conditions.

Some of the notable clinical nutrition market players in U.S. are Abbott Laboratories, B Braun Melsungen AG, Baxter International Inc., Danone, Fresenius Kabi and Nestle.